bms-906024

chemical compound

Uses your system voice; voice and rate in settings.

Q15408421Snapshot

≈ 1 min read

Names in other languages

  • Englishbms-906024
  • ItalianoBMS-906024
  • shBMS-906024
  • СрпскиBMS-906024

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

BMS-906024 is a drug with a benzodiazepine structure, developed by Bristol-Myers Squibb and disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, colon cancers and leukemia. The drug works as a pan-Notch inhibitor. The structure is one of a set patented in 2012, and is being studied in clinical trials.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330130981 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot bms-906024-1680925-18992c070fa11c6e · hash 18992c070fa11c6ef8d56d86d2423e608cee68ddd99f5532bae4f2b9001b884e · captured 2025-12-29 · not yet sealed in the ledger · verify the chain · version history

Cite this page as: encyclopegia.org, “bms-906024”, snapshot bms-906024-1680925-18992c070fa11c6e. https://encyclopegia.org/a/bms-906024

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.